A study on the effect of LAB (heat-killed) on Visceral Fat.
- Conditions
- o
- Registration Number
- JPRN-UMIN000037620
- Lead Sponsor
- Kagome Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Not provided
(1)Who use medicines that may affect obesity, hyperlipidemia, lipid metabolism. (2)Who has such serious diseases as liver disease, cardiovascular disease, respiratory disease, endocrine disorder, metabolic disease, food allergy disease. (3)Who cannot stop intake health foods or supplements which may affect obesity, hyperlipidemia, lipid metabolism, during this study. (4)Who has a current or history of drug dependence and/or alcoholism. (5)Who has been implanted metal in the DUAL SCAN measurement site. (6)Who has implantable medical devices (e.g., cardiac pacemaker and/or implantable defibrillator). (7)Who has been diagnosed as familial hyperlipidemia. (8)Who is pregnant or breast-feeding or willing to be pregnant during this study. (9)Who has an irregular diet, and/or is shift worker and/or midnight-shift worker. (10)Who is planning to participate and/or has participated in other clinical studies. (11)Who is judged as unsuitable for this study by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visceral fat area
- Secondary Outcome Measures
Name Time Method Abdominal subcutaneous fat area, total fat area, body weight (BMI), blood pressure, body fat percentage, muscle mass, waist/hip circumference, AST (GOT), ALT (GPT), gamma-GTP, total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, blood glucose level, insulin, HbA1c, HOMA-IR, fecal microbiota.